Quest Launches EGFR Test for Erbitux, Vectibix Users Based on Somalogic's Somamer Technology
September 21, 2012
Quest Launches EGFR Test for Erbitux, Vectibix Users Based on Somalogic's Somamer Technology
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Conference Discussion Questions Big Pharma's True Motivations for Pursuing Personalized Medicine
December 2, 2009 / Pharmacogenomics Reporter - Qiagen Enters Companion Dx Market with Approval of KRAS Test Kit for Erbitux; LDT Impact Unknown
July 11, 2012 / Pharmacogenomics Reporter - After FDA Letter Seeking More Data, Lilly Won't Pursue CDx-Guided Erbitux in NSCLC in the US
May 2, 2012 / Pharmacogenomics Reporter - Bypassing Phosphorylation, Vandy Team Gauges Kinase Inhibitor Response via Protein Expression Levels
December 9, 2011 / ProteoMonitor - With Novartis Deal, Release of New Discovery Panel, Somalogic Targets Proteomics Services Market
October 21, 2011 / ProteoMonitor